Bio Protech Inc.

A199290

KR7199290008

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-09 pm EDT			5-day change	1st Jan Change
771 ^KRW	+2.25%		-3.02%	-15.27%

2023	Bio Protech Inc. announced that it has received KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.	CI
2023	Bio Protech Inc. announced that it expects to receive KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.	CI

Bio Protech Inc. announced that it has received KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.

May 02, 2023

On May 3, 2023, Bio Protech Inc. closed the transaction.

Latest news about Bio Protech Inc.

Bio Protech Inc. announced that it has received KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.	23-05-02	CI
Bio Protech Inc. announced that it expects to receive KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.	23-04-17	CI
Bio Protech Inc. announced that it expects to receive KRW 499.9995 million in funding	22-11-24	CI
Bio Protech Inc. announced that it has received KRW 500 million in funding	22-02-09	CI
Bio Protech Inc. announced that it expects to receive KRW 500 million in funding	22-02-08	CI
Bio Protech Inc. announced that it has received KRW 289.998 million in funding from Mijin Company Co., Ltd.	22-01-23	CI
Bio Protech Inc. announced that it has received KRW 169.48125 million in funding	21-12-29	CI
Bio Protech Inc. cancelled the transaction announced on December 9, 2021	21-12-27	CI
Bio Protech Inc. cancelled the transaction announced on December 2, 2021	21-12-27	CI
Bio Protech Inc. announced a financing transaction	21-12-08	CI
Bio Protech Inc. announced that it expects to receive KRW 500 million in funding from Mijin Company Co., Ltd.	21-12-07	CI
Bio Protech Inc. announced that it expects to receive KRW 169.48125 million in funding	21-12-01	CI
Bio Protech Inc. announced that it expects to receive KRW 1.4999985 billion in funding from Mijin Company Co., Ltd, and other investors	21-12-01	CI
Bio Protech Inc. announced that it has received KRW 150 million in funding from T Investment, Mijin Company Co., Ltd.	21-07-08	CI
Bio Protech Inc. announced that it expects to receive KRW 150 million in funding from T Investment, Mijin Company Co., Ltd.	21-07-07	CI
Bio Protech Inc. announced that it has received KRW 2 billion in funding	21-04-15	CI
Bio Protech Inc. announced that it expects to receive KRW 2 billion in funding	21-04-08	CI
Bio Protech Inc. announced that it has received KRW 540 million in funding	21-04-05	CI
Bio Protech Inc. announced that it has received KRW 2 billion in funding	21-03-17	CI
Bio Protech Inc. announced that it has received KRW 500 million in funding	20-02-13	CI
Bio Protech Inc. announced that it has received KRW 1 billion in funding	19-08-04	CI
Bio Protech Inc. announced that it expects to receive KRW 1 billion in funding	19-08-01	CI
Bio Protech Inc. announced that it has received KRW 3 billion in funding	19-07-10	CI
Bio Protech Inc. announced that it expects to receive KRW 3 billion in funding	19-07-08	CI
Nau Ib Capital, C Squared Asset Management Co., Ltd. and Yangtze River Delta Venture Capital Fund, a fund managed by DT Capital Partners and Delta Venture Capital Investment Management Company acquired 11.94% stake in Bio Protech Inc. (XKON : A199290) from KoFC-Neoplux Pioneer Champ 2010-7, a fund managed by Neoplux Co., Ltd. for KRW 1 billion.	19-05-20	CI

BIO PROTECH INC. is a Korea-based company mainly engaged in manufacture of medical equipment. The Company's products mainly consist of electrocardiogram electrodes, which are used for electrocardiogram tests, electrosurgery plates, electrosurgery pencils and transcutaneous electrical nerve stimulators (TENS) electrodes, which are used for providing conductive interface between the TENS generator and the patientâs skin.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
BIO PROTECH INC.	-15.27%	8.07M
SARTORIUS AG	-28.84%	15.51B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+13.74%	1.79B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-17.93%	1.36B
BIOTAGE AB	+24.23%	1.28B
REVENIO GROUP OYJ	+11.27%	823M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-35.69%	738M
CONTEC MEDICAL SYSTEMS CO.,LTD	-39.26%	692M
CELLAVISION AB	+28.54%	605M
VAREX IMAGING CORPORATION	-31.46%	574M

Medical Diagnostic & Testing Equipment

Bio Protech Inc.

Equities

A199290

KR7199290008

Advanced Medical Equipment & Technology

Bio Protech Inc. announced that it has received KRW 2.299996268 billion in funding from Korea Investment & Securities Co., Ltd., Nine Tree Investment Co., Ltd.

Latest news about Bio Protech Inc.

Chart Bio Protech Inc.

Company Profile

Sector Medical Diagnostic & Testing Equipment